Insilico Medicine IPOs on HKEX as 2025's Largest Biotech Listing
Insilico Medicine, backed by Qiming Venture Partners, listed on HKEX as 2025's largest biotech IPO, valued at HK$19.51 billion. The AI-driven drug discovery company aims to extend human healthspan.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.